Author Topic: (AAN abst.) Recovery from COVID-19 in people w/MS: UK prospective cohort study  (Read 36 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
Presented at the annual AAN conference, held virtually April 17-22, 2021--"Determinants for recovery from the coronavirus 2019 in people with multiple sclerosis:  The UK Register COVID-19 Prospective Cohort Study":


https://index.mirasmart.com/AAN2021/PDFfiles/AAN2021-004285.html


An article about this study in Multiple Sclerosis News Today (April 23, 2021)--"COVID-19 often leads to flares in MS patients, survey finds":


https://bit.ly/3xs248P
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
86 Views
Last post April 12, 2016, 08:40:06 pm
by agate
0 Replies
101 Views
Last post December 13, 2016, 07:26:06 am
by agate
0 Replies
81 Views
Last post April 01, 2018, 01:43:26 pm
by agate
0 Replies
52 Views
Last post December 05, 2020, 03:54:45 pm
by agate
0 Replies
23 Views
Last post December 02, 2021, 09:15:53 pm
by agate